(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-2.53% $ 1.930
Live Chart Being Loaded With Signals
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina...
Stats | |
---|---|
Dzisiejszy wolumen | 63 329.00 |
Średni wolumen | 199 883 |
Kapitalizacja rynkowa | 75.27M |
EPS | $0 ( 2024-05-04 ) |
Następna data zysków | ( $-0.250 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.24 |
ATR14 | $0.0130 (0.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Doyle John Brendan | Sell | 8 699 | Common Stock |
2024-03-14 | Ricciardi Lisa | Buy | 5 700 | Common Stock |
2024-02-15 | Doyle John Brendan | Buy | 20 000 | Common Stock |
2024-02-15 | Doyle John Brendan | Buy | 20 000 | Stock Option (Right to Buy) |
2024-02-15 | Caggiano Anthony | Buy | 60 000 | Common Stock |
INSIDER POWER |
---|
96.32 |
Last 94 transactions |
Buy: 12 485 685 | Sell: 1 489 688 |
Wolumen Korelacja
Cognition Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
BOWXU | 0.909 |
AYLA | 0.897 |
AGCUU | 0.896 |
ASPS | 0.896 |
IRBT | 0.894 |
ARQQ | 0.878 |
AMD | 0.876 |
CELU | 0.875 |
OP | 0.873 |
SNPS | 0.872 |
10 Najbardziej negatywne korelacje | |
---|---|
IVAC | -0.894 |
ULTA | -0.889 |
ISEM | -0.884 |
PAHC | -0.882 |
CTLP | -0.879 |
RCM | -0.877 |
WFRD | -0.876 |
STAY | -0.872 |
IQ | -0.872 |
IDLB | -0.865 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cognition Therapeutics, Korelacja - Waluta/Towar
Cognition Therapeutics, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-252 000 (0.00 %) |
EPS: | $-0.860 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-252 000 (0.00 %) |
EPS: | $-0.860 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-235 000 (0.00 %) |
EPS: | $0.0261 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.548 |
Financial Reports:
No articles found.
Cognition Therapeutics,
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej